In a statement released on January 26, 2017, the National Agency for Drug Safety recalls the danger of nonsteroidal anti-inflammatory drugs (NSAIDs) from the 6th month of pregnancy.
- In a statement of January 26, 2017, the National Agency for Drug Safety (ANSM) reminded that nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen or aspirin, are contraindicated as of the 6th month of pregnancyor beyond 24 weeks of amenorrhea.
- Prescribed to relieve a large number of conditions (dental care, angina, low back pain, otitis, migraines, gynecological pain ...) or to reduce fever, NSAIDs can have serious consequences, even fatal, for the fetus or for the newborn.
From the first dose, these drugs are likely to cause the closure of the arterial duct allowing blood exchanges between the fetus and the future mother. The organs of the future baby are then deprived of oxygen, which can lead to death in utero. Repeated taking qaunt to it can affect the functioning of the kidneys of the fetus, ultimately causing kidney failure. These risks are not new and listed in the drug leaflets.
- This contraindication concerns all NSAIDs, including aspirin, whether taken on medical prescription or not, and regardless of the route of administration, oral, injectable or cutaneous (the passage in the blood of NSAIDs is even more important than the application is carried out on a large cutaneous surface, in occlusive dressing for example).
- ANSM reminds that self-medication is to be avoided during pregnancy and that you should always seek the advice of your doctor or pharmacist before consuming this type of medication. Alternative solutions exist to cure oneself pregnant. It also recalls that any drug treatment must be reevaluated during pregnancy.
More information on the ANSM website